Theratechnologies Eulerpool naujienos

Theratechnologies akcijų naujienos

Theratechnologies stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Theratechnologies naujienas mes pateikiame čia.

• sausio 9 d. ·

  Yahoo
  Theratechnologies Provides Update on EGRIFTA SV® Supply
• gruodžio 10 d. ·

  Yahoo
  Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA
• gruodžio 9 d. ·

  Yahoo
  Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
• gruodžio 4 d. ·

  Yahoo
  Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada
• lapkričio 26 d. ·

  Yahoo
  Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review
• lapkričio 25 d. ·

  Yahoo
  Theratechnologies Inc. (TSE:TH) Has Found A Path To Profitability
• spalio 17 d. ·

  Yahoo
  Theratechnologies Unveils Study Design of PROMISE-US Trial of Ibalizumab
• spalio 17 d. ·

  Yahoo
  Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
• spalio 11 d. ·

  Yahoo
  Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
• spalio 10 d. ·

  Yahoo
  Theratechnologies Up 12% in U.S. Premarket Trading After Reporting Q3 Swing to Profit